SAN FRANCISCO--(BUSINESS WIRE)--The Institute for OneWorld Health (iOWH), the US-based non-profit pharmaceutical company that develops drugs for people with infectious diseases in the developing world, today announced that an article describing groundbreaking research in semisynthetic artemisinin has been published in the American Journal of Tropical Medicine and Hygiene’s (AJTMH) special malaria burden supplement Defining and Defeating the Intolerable Burden of Malaria III: Progress and Perspectives.
